Results 101 to 110 of about 35,915 (205)

Crystallization of [Zn(Pyrazinamide)₂(Cl)₂] Complex and In Vitro Antibacterial Activity of the Complex Against E. coli and S. aureus

Jurnal Kimia Sains dan Aplikasi
A complex of [Zn(pza)2(Cl)2], pza = pyrazinamide, was successfully crystallized from methanol or ethanol solvents with different morphology. The complex was synthesized using the solution method in ZnCl2: pza mol ratios of 1:2 and 1:4 in both ethanol and
Naila Azmi Adiba, Danar Purwonugroho, Arie Srihardyastutie, Yuniar Ponco Prananto   +3 more
doaj   +1 more source

The Results of Treatment with Streptomycin Plus Pyrazinamide in Patients with Active Pulmonary Tuberculosis Despite Prolonged Treatment with Isoniazid Plus PAS [PDF]

, 1960
This report presents the findings during a year or more of observation of 20 South Indian patients who, after an initial course of isoniazid plus PAS, were treated with streptomycin plus pyrazinamide for active pulmonary tuberculosis.
Andrews, R H, Devadatta, S, Fox, Wallace, Velu, S   +3 more
core  

Thermodynamic Assessment of the Pyrazinamide Dissolution Process in Some Organic Solvents

Molecules
Pyrazinamide is a first line drug used for the treatment of tuberculosis, a pathology that caused the death of more than 1.3 million people in the world during 2022, according to WHO, being a drug of current interest due to its relevance in ...
Jesus Tovar-Amézquita, Cristian Rincón-Guio, Francy Elaine Torres-Suarez, Magda Melissa Florez, Claudia Patricia Ortiz, Fleming Martinez, Daniel Ricardo Delgado   +6 more
doaj   +1 more source

Mitigating Tuberculosis Drug-induced Liver Injury: The Role of Moringa oleifera and Other Herbal Extracts

International Journal of Mycobacteriology
Background: Tuberculosis (TB) is a significant public health issue, and drug-induced liver injury (DILI) from anti-TB medications poses a major challenge to treatment efficacy.
Herin Mawarti, Khotimah Khotimah, Yuly Peristiowati, Christina Destri Wiwis Wijayanti, Rizky Meuthia Pratiwi   +4 more
doaj   +1 more source

Pharmacokinetic modelling as a tool to assess TB treatment adherence: application to the REMEMBER study. [PDF]

IJTLD Open
Abdelgawad N, Chirehwa M, McIlleron H, Kanyama C, Mwelase N, Naidoo A, Kumwenda J, Nyirenda M, Samaneka WP, Lama JR, Mohapi L, Mave V, Veloso VG, Valencia J, Gupta A, Hosseinipour MC, Scarsi K, Denti P.   +17 more
europepmc   +1 more source

Population pharmacokinetics of pyrazinamide and ethambutol in children with tuberculosis with or without HIV. [PDF]

Antimicrob Agents Chemother
Maranchick NF, Martyn-Dickens C, Enimil A, Yang H, Amissah AK, Dompreh A, Bosomtwe D, Sly-Moore E, Opoku T, Frimpong Appiah A, Asiedu P, Antwi S, Scheetz MH, Peloquin CA, Kwara A.   +14 more
europepmc   +1 more source

Rechallenge with First-Line Anti-Tubercular Therapy After Toxic Epidermal Necrolysis in an HIV-Positive Patient with Tubercular Pleural Effusion. [PDF]

Indian Dermatol Online J
Narula AS, Mathews J, Ashraf F, Khadanga S.   +3 more
europepmc   +1 more source

Cutaneous Tuberculosis Presenting as a Chronic Dermatologic Disorder. [PDF]

Case Rep Dermatol Med
Spina O, Fraimow H, Green J.
europepmc   +1 more source

Tuberculous spondylodiscitis following intravesical Bacille Calmette-Guérin therapy: A case report and systematic literature review. [PDF]

Surg Neurol Int
Kazami K, Narikiyo M, Hirokawa Y, Miyazaki R, Ohashi S, Nagasaki H, Tsuboi Y, Matsuoka H.   +7 more
europepmc   +1 more source